close

Register today to unlock Valuecruncher and get unlimited access

  • Get unlimited access to all compartors and data
  • Save and share valuations as well as comment on others
  • Alter and save your favourite comparator companies

Already registered? Please login now

Comparison Analysis (switch to Discounted Cash Flow Analysis)
Dollar1Point03
Implied share price

Sell Overvalued by 49.8%

5% margin of safety What's this?

EV / Revenue
Use Average
COM
Cardiome Pharma Corp.
SNY
Sanofi SA (ADR)
Change
DNA
Genentech, Inc.
Change
GILD
Gilead Sciences, Inc.
Change
AMGN
Amgen, Inc.
Change
5.2 21.26 2.23 7.2 8.82 4.45
All amounts in millions
from last financial year
         
Implied Share Price $1.03 $135.06 $69.38 $28.88 $116.31
Market Cap 25 145,789 100,042 79,226 74,307
Net Debt -8 8,094 -3,369 6,361 2,468
Enterprise Value (EV) 16 80,290 96,673 85,588 76,775
Revenue 0 35,957 13,418 9,702 17,265
Balance Sheet          
Total Assets 44 100,407 21,787 21,239 54,298
Total Liabilities 36 43,069 6,116 11,930 35,238
Shareholders Equity 7 57,338 15,671 9,309 19,060.0

Where are the EBIT and EBITDA figures?

Certain companies and those in specific industries (for example insurance) do not report financial results at the EBIT or EBITDA line. For these companies where Valuecruncher does not have EBIT or EBITDA numbers we exclude the valuation metrics driven by these figures. Valuecruncher makes our other valuation metrics available for these companies.

To learn more about comparison analysis, please read our guide to comparison analysis

Comments

No comments yet. Login to comment.